269 related articles for article (PubMed ID: 18756111)
21. A recombinant, membrane-acting immunotoxin.
Chovnick A; Schneider WP; Tso JY; Queen C; Chang CN
Cancer Res; 1991 Jan; 51(2):465-7. PubMed ID: 1898711
[TBL] [Abstract][Full Text] [Related]
22. [Construction and expression of mouse-human chimeric Fab fragment gene of monoclonal antibody SZ-2 against platelet].
Dai KS; Zhu HP; Jiang M; Ruan CG
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2003 Jan; 19(1):71-3, 79. PubMed ID: 15132913
[TBL] [Abstract][Full Text] [Related]
23. [Expression, purification, and characterization of single-chain disulfide-bond Fv (ScdsFv) antibody fused with targeted superantigen SEA (D227A)].
Hao HJ; Zheng YL; Yu DW; Ma R; Jiang YQ
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2005 May; 21(3):269-72. PubMed ID: 15862136
[TBL] [Abstract][Full Text] [Related]
24. [Expression of human Fab antibody against keratin in E.coli and its renaturation].
Fan JY; Wang G; Li W; Wu YM; Liu YF
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2004 Jul; 20(4):441-3. PubMed ID: 15207090
[TBL] [Abstract][Full Text] [Related]
25. X-ray structure of the uncomplexed anti-tumor antibody BR96 and comparison with its antigen-bound form.
Sheriff S; Chang CY; Jeffrey PD; Bajorath J
J Mol Biol; 1996 Jun; 259(5):938-46. PubMed ID: 8683596
[TBL] [Abstract][Full Text] [Related]
26. [Molecular design and construction of IL6D24-PE40KDEL, a novel recombinant interleukin6-pseudomonas exotoxin fusion protein, having targeted cytotoxicity for leukemias expressing interleukin6 receptors].
Zheng LY; Xi YZ; Kong FH; Cui JW; Liang F; Liu N; Sun YY; Guo SQ
Zhonghua Yi Xue Za Zhi; 2003 Jul; 83(14):1246-50. PubMed ID: 12930640
[TBL] [Abstract][Full Text] [Related]
27. Rapid expression of vaccine proteins for B-cell lymphoma in a cell-free system.
Yang J; Kanter G; Voloshin A; Michel-Reydellet N; Velkeen H; Levy R; Swartz JR
Biotechnol Bioeng; 2005 Mar; 89(5):503-11. PubMed ID: 15669088
[TBL] [Abstract][Full Text] [Related]
28. Purification of clinical-grade disulfide stabilized antibody fragment variable--Pseudomonas exotoxin conjugate (dsFv-PE38) expressed in Escherichia coli.
Jiang H; Xie Y; Burnette A; Roach J; Giardina SL; Hecht TT; Creekmore SP; Mitra G; Zhu J
Appl Microbiol Biotechnol; 2013 Jan; 97(2):621-32. PubMed ID: 22890777
[TBL] [Abstract][Full Text] [Related]
29. Cloning and expression in E. coli of a functional Fab fragment obtained from single human lymphocyte against anthrax toxin.
Masri SA; Rast H; Hu WG; Nagata LP; Chau D; Jager S; Mah D
Mol Immunol; 2007 Mar; 44(8):2101-6. PubMed ID: 17045651
[TBL] [Abstract][Full Text] [Related]
30. Administration of disulfide-stabilized Fv-immunotoxins B1(dsFv)-PE38 and B3(dsFv)-PE38 by continuous infusion increases their efficacy in curing large tumor xenografts in nude mice.
Benhar I; Reiter Y; Pai LH; Pastan I
Int J Cancer; 1995 Jul; 62(3):351-5. PubMed ID: 7628878
[TBL] [Abstract][Full Text] [Related]
31. Improved affinity of a human anti-Entamoeba histolytica Gal/GalNAc lectin Fab fragment by a single amino acid modification of the light chain.
Tachibana H; Matsumoto N; Cheng XJ; Tsukamoto H; Yoshihara E
Clin Diagn Lab Immunol; 2004 Nov; 11(6):1085-8. PubMed ID: 15539510
[TBL] [Abstract][Full Text] [Related]
32. Rapid humanization of the Fv of monoclonal antibody B3 by using framework exchange of the recombinant immunotoxin B3(Fv)-PE38.
Benhar I; Padlan EA; Jung SH; Lee B; Pastan I
Proc Natl Acad Sci U S A; 1994 Dec; 91(25):12051-5. PubMed ID: 7991583
[TBL] [Abstract][Full Text] [Related]
33. Studies in serum support rapid formation of disulfide bond between unpaired cysteine residues in the VH domain of an immunoglobulin G1 molecule.
Ouellette D; Alessandri L; Chin A; Grinnell C; Tarcsa E; Radziejewski C; Correia I
Anal Biochem; 2010 Feb; 397(1):37-47. PubMed ID: 19766583
[TBL] [Abstract][Full Text] [Related]
34. Antibody engineering of recombinant Fv immunotoxins for improved targeting of cancer: disulfide-stabilized Fv immunotoxins.
Reiter Y; Pastan I
Clin Cancer Res; 1996 Feb; 2(2):245-52. PubMed ID: 9816166
[TBL] [Abstract][Full Text] [Related]
35. [Preparation of human Fab antibodies against HAb18G by guided selection and chain shuffling technique].
Bao GQ; Ma QJ; Xing JL; Yang XM; Chen ZN
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2004 Jul; 20(4):437-40. PubMed ID: 15207089
[TBL] [Abstract][Full Text] [Related]
36. Domain interactions in the Fab fragment: a comparative evaluation of the single-chain Fv and Fab format engineered with variable domains of different stability.
Röthlisberger D; Honegger A; Plückthun A
J Mol Biol; 2005 Apr; 347(4):773-89. PubMed ID: 15769469
[TBL] [Abstract][Full Text] [Related]
37. Intrachain disulfide bond in the core hinge region of human IgG4.
Bloom JW; Madanat MS; Marriott D; Wong T; Chan SY
Protein Sci; 1997 Feb; 6(2):407-15. PubMed ID: 9041643
[TBL] [Abstract][Full Text] [Related]
38. chFRP5-ZZ-PE38, a large IgG-toxin immunoconjugate outperforms the corresponding smaller FRP5(Fv)-ETA immunotoxin in eradicating ErbB2-expressing tumor xenografts.
Mazor Y; Noy R; Wels WS; Benhar I
Cancer Lett; 2007 Nov; 257(1):124-35. PubMed ID: 17698286
[TBL] [Abstract][Full Text] [Related]
39. Immobilization and functional reconstitution of antibody Fab fragment by solid-phase refolding.
Kumada Y; Hamasaki K; Nakagawa A; Sasaki E; Shirai T; Okumura M; Inoue M; Kishimoto M
J Immunol Methods; 2013 Dec; 400-401():70-7. PubMed ID: 24177435
[TBL] [Abstract][Full Text] [Related]
40. Engineered antibody intervention strategies for Alzheimer's disease and related dementias by targeting amyloid and toxic oligomers.
Robert R; Dolezal O; Waddington L; Hattarki MK; Cappai R; Masters CL; Hudson PJ; Wark KL
Protein Eng Des Sel; 2009 Mar; 22(3):199-208. PubMed ID: 18927231
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
